185.77
-0.94 (-0.50%)
| Penutupan Terdahulu | 186.70 |
| Buka | 183.84 |
| Jumlah Dagangan | 558,243 |
| Purata Dagangan (3B) | 2,059,747 |
| Modal Pasaran | 30,536,394,752 |
| Harga / Pendapatan (P/E TTM) | 34.21 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.92 |
| Harga / Jualan (P/S) | 9.68 |
| Harga / Buku (P/B) | 4.22 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 May 2026 |
| Margin Keuntungan | 27.34% |
| Margin Operasi (TTM) | 30.79% |
| EPS Cair (TTM) | 4.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 41.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.24% |
| Nisbah Semasa (MRQ) | 4.61 |
| Aliran Tunai Operasi (OCF TTM) | 1.20 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.05 B |
| Pulangan Atas Aset (ROA TTM) | 6.90% |
| Pulangan Atas Ekuiti (ROE TTM) | 14.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Menurun |
| Health Information Services (Global) | Menurun | Menurun | |
| Stok | Veeva Systems Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.20 |
|
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 8.55% |
| % Dimiliki oleh Institusi | 86.32% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Linonia Partnership Lp | 31 Dec 2025 | 2,800,018 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 317.00 (Wells Fargo, 70.65%) | Beli |
| Median | 270.00 (45.35%) | |
| Rendah | 215.00 (Morgan Stanley, 15.74%) | Pegang |
| Purata | 265.07 (42.69%) | |
| Jumlah | 11 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 192.32 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 09 Mar 2026 | 291.00 (56.65%) | Beli | 195.57 |
| Canaccord Genuity | 05 Mar 2026 | 235.00 (26.50%) | Pegang | 196.06 |
| Evercore ISI Group | 05 Mar 2026 | 240.00 (29.20%) | Pegang | 196.06 |
| Morgan Stanley | 05 Mar 2026 | 215.00 (15.74%) | Pegang | 196.06 |
| 17 Feb 2026 | 205.00 (10.35%) | Pegang | 176.82 | |
| Needham | 05 Mar 2026 | 270.00 (45.34%) | Beli | 196.06 |
| Piper Sandler | 05 Mar 2026 | 285.00 (53.42%) | Beli | 196.06 |
| RBC Capital | 05 Mar 2026 | 275.00 (48.04%) | Beli | 196.06 |
| Stifel | 05 Mar 2026 | 245.00 (31.89%) | Beli | 196.06 |
| 26 Feb 2026 | 212.00 (14.12%) | Beli | 182.86 | |
| TD Cowen | 05 Mar 2026 | 300.00 (61.49%) | Beli | 196.06 |
| Truist Securities | 05 Mar 2026 | 262.00 (41.04%) | Beli | 196.06 |
| UBS | 05 Mar 2026 | 220.00 (18.43%) | Pegang | 196.06 |
| 20 Feb 2026 | 200.00 (7.66%) | Pegang | 180.31 | |
| Wells Fargo | 05 Mar 2026 | 317.00 (70.65%) | Beli | 196.06 |
| Barclays | 25 Feb 2026 | 250.00 (34.58%) | Beli | 176.46 |
| Oppenheimer | 24 Feb 2026 | 275.00 (48.04%) | Beli | 175.79 |
| JP Morgan | 20 Feb 2026 | 296.00 (59.34%) | Beli | 180.31 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| SCHWENGER THOMAS D. | - | 196.06 | -1,000 | -196,060 |
| Jumlah Keseluruhan Kuantiti Bersih | -1,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -196,060 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 196.06 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| SCHWENGER THOMAS D. | Pegawai | 05 Mar 2026 | Jual automatik (-) | 1,000 | 196.06 | 196,060 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | 13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People |
| 29 Jan 2026 | Pengumuman | Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow |
| 27 Jan 2026 | Pengumuman | Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises |
| 08 Jan 2026 | Pengumuman | Veeva to Present at the J.P. Morgan 2026 Healthcare Conference |
| 08 Jan 2026 | Pengumuman | Veeva and BioMarin Form Long-Term Strategic Partnership |
| 08 Jan 2026 | Pengumuman | Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing |
| 07 Jan 2026 | Pengumuman | Novo Nordisk International Operations Commits to Veeva Vault CRM |
| 05 Jan 2026 | Pengumuman | Veeva Announces Share Repurchase Program |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |